Ireland - English - HPRA (Health Products Regulatory Authority)

ibsa farmaceutici italia s.r.l - urofollitropin - powder and solvent for solution for injection - 225 international unit(s) - gonadotropins; urofollitropin

Ireland - English - HPRA (Health Products Regulatory Authority)

ibsa farmaceutici italia s.r.l - urofollitropin - powder and solvent for solution for injection - 300 international unit(s) - gonadotropins; urofollitropin

Ireland - English - HPRA (Health Products Regulatory Authority)

ibsa farmaceutici italia s.r.l - urofollitropin - powder and solvent for solution for injection - 75 international unit(s) - gonadotropins; urofollitropin

Singapore - English - HSA (Health Sciences Authority)

merck pte. ltd. - follitropin alfa - injection, solution - 22.23 mcg - follitropin alfa 22.23 mcg

Singapore - English - HSA (Health Sciences Authority)

merck pte. ltd. - follitropin alfa - injection, solution - 33.34 mcg - follitropin alfa 33.34 mcg

European Union - English - myHealthbox

finox biotech ag - follitropin alfa - solution for injection in pre-filled pen (injection). - 75 iu/0.125ml - anovulation - sex hormones and modulators of the genital systems - in adult women - anovulation (including polycystic ovarian disease, pcod) in women who have been unresponsive to treatment with clomiphene citrate. - stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (art) such as in vitro fertilisation (ivf), gamete intra-fallopian transfer (gift) and zygote intra-fallopian transfer (zift). - follitropin alfa in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. in clinical trials these patients were defined by an endogenous serum lh level < 1.2 iu/l. in adult men - follitropin alfa is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotrophic hypogonadism with concomitant human chorionic gonadotrophin (hcg) therapy.

European Union - English - EMA (European Medicines Agency)

n.v. organon - corifollitropin alfa - reproductive techniques, assisted; ovulation induction; investigative techniques - sex hormones and modulators of the genital system, - controlled ovarian stimulation (cos) in combination with a gnrh antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (art) program.elonva is indicated for the treatment of adolescent males (14 to less than 18 years and older) with hypogonadotropic hypogonadism, in combination with human chorionic gonadotropin (hcg).

European Union - English - EMA (European Medicines Agency)

merck sharp & dohme b.v.  - follitropin beta - infertility; hypogonadism - sex hormones and modulators of the genital system, - in the female:fertavid is indicated for the treatment of female infertility in the following clinical situations:anovulation (including polycystic ovarian disease, pcod) in women who have been unresponsive to treatment with clomifene citratecontrolled ovarian hyperstimulation to induce the development of multiple follicles in medically assisted reproduction programs [e.g. in vitro fertilisation/embryo transfer (ivf/et), gamete intra-fallopian transfer (gift) and intracytoplasmic sperm injection (icsi).in the male:deficient spermatogenesis due to hypogonadotrophic hypogonadism.

European Union - English - EMA (European Medicines Agency)

merck europe b.v. - follitropin alfa - anovulation; reproductive techniques, assisted; infertility, female; hypogonadism - sex hormones and modulators of the genital system, - anovulation (including polycystic ovarian disease, pcod) in women who have been unresponsive to treatment with clomiphene citrate.stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (art) such as in-vitro fertilisation (ivf), gamete intra-fallopian transfer (gift) and zygote intra-fallopian transfer (zift).gonal-f in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. in clinical trials these patients were defined by an endogenous serum lh level

European Union - English - EMA (European Medicines Agency)

n.v. organon - follitropin beta - infertility; hypogonadism - sex hormones and modulators of the genital system, - in the female:puregon is indicated for the treatment of female infertility in the following clinical situations:anovulation (including polycystic ovarian syndrome, pcos) in women who have been unresponsive to treatment with clomifene citrate;controlled ovarian hyperstimulation to induce the development of multiple follicles in medically assisted reproduction programs (e.g. in-vitro fertilisation / embryo transfer (ivf/et), gamete intrafallopian transfer (gift) and intracytoplasmic sperm injection (icsi)).in the male:deficient spermatogenesis due to hypogonadotrophic hypogonadism.